A Mayo Clinic study published in the Journal of Neuro-Oncology shows that cerebrospinal fluid liquid biopsy can detect brain tumor DNA in complex cases where traditional MRI or tissue biopsies fall short. Analyzing samples from 76 patients facing diagnostic uncertainty, researchers identified tumor-associated DNA in 20 individuals (26%). While tissue biopsy remains the gold standard, CSF testing provides critical genomic insights when surgical sampling is unsafe, offering potential pathways to targeted therapies and clinical trials.
Results of the Mayo Clinic study
- ▪A Mayo Clinic study in Journal of Neuro-Oncology evaluated 76 patients facing complex brain clinical scenarios; 20 had tumor-associated DNA, 29 had DNA without tumor DNA, and 27 lacked sufficient usable DNA.
- ▪The Mayo Clinic study evaluated 35 patients with uncertain brain abnormalities, 21 with unclear imaging changes, and 20 evaluated for suspected leptomeningeal disease.
Future applications and research directions
- ▪Mayo Clinic researchers state that analyzing cell-free DNA in cerebrospinal fluid could help identify clinical trials and targeted treatments for specific genetic changes.
- ▪Mayo Clinic researchers are working to improve detection in low-quantity DNA samples and evaluate how biomarker changes over time reflect tumor treatment response.
How cerebrospinal fluid liquid biopsy works
- ▪Cerebrospinal fluid liquid biopsy analyzes cell-free DNA fragments shed into fluid surrounding the brain and spinal cord, which can be collected via lumbar puncture.
- ▪Brain tumor cell-free DNA detection in blood is limited by the blood-brain barrier, making cerebrospinal fluid liquid biopsy an alternative detection method.
Limitations of traditional diagnostic methods
- ▪Traditional tissue biopsies carry potential complications including tumor spread, injury to surrounding tissue, and severe bleeding.
- ▪Obtaining brain tissue through standard biopsy can be difficult or unsafe depending on a lesion's location within the brain or spinal cord.
- ▪Magnetic resonance imaging changes can look similar whether caused by cancer, inflammation, or treatment effects, creating diagnostic uncertainty in brain tumor care.
Story comments
Loading comments…